Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2.

Source:http://linkedlifedata.com/resource/pubmed/id/9153295

J. Clin. Invest. 1997 May 15 99 10 2509-17

Download in:

View as

General Info

PMID
9153295